In view of reported discrepancies between different factor VIII assays
, the influence of phospholipids on the performance of one-stage clott
ing (OS) and chromogenic substrate (CS) assays was evaluated. The 13 d
omain deleted recombinant factor VIII, rVIII SQ, two full-length recom
binant products and a plasma derived factor VDI concentrate were each
diluted into severe haemophilia A plasma and assayed against a plasma
standard. The one-stage activity was 50, 80, 75 and 106%, respectively
, of the chromogenic result. Variations in the phospholipid concentrat
ion did not affect the chromogenic assay, except at very low levels wh
ere the apparent activity increased. In contrast, dilution of the phos
pholipid reagent had a substantial influence on the activity measured
by OS assays, especially in the case of rVIII SQ. At low levels of pho
spholipid, the one-stage activity of rVIII: SQ exceeded the chromogeni
c result. When mixtures of phosphatidylserine (PS) and phosphatidyl-ch
oline (PC) were used as a source of phospholipid, the OS results for r
VIII SQ agreed well with the CS activity as long as the content of PS
was below 10%, i.e., closer to the physiological level. At higher leve
ls of PS, as in most commercial APTT reagents, the OS activity decreas
ed. When the APTT reagent was replaced by platelets in the OS assay, t
he results compared well with those obtained by the CS assay for both
t-VIII SQ and full-length factor VIII products.